Drug Trial Radar · NCT01262456
Investigation of the Superiority Effect of Orally Disintegrating Desmopressin Tablets to Placebo in Terms of Night Voids Reduction in Nocturia Adult Male Patients
Last checked: Nov 19, 2026Latest source record: Oct 15, 2015 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
395
Actual
Start
Feb 2011
Primary completion
Jan 2012
Study completion Jan 2012
Sponsor
- Lead sponsor
- Ferring PharmaceuticalsIndustry
- Sponsor type
- Industry
- First posted
- Dec 17, 2010
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- Who can join
- Male only, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this trial was to confirm/establish long-term safety and efficacy of desmopressin orally disintegrating tablets at dose levels of 50 μg and 75 μg and to further evaluate the safety of an efficacious higher dose level of 100 μg in males with nocturia.
Conditions
- Nocturia
Interventions
DesmopressinDrug
PlaceboDrug
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change From Baseline in Mean Number of Nocturnal Voids Averaged Over a 3-Month PeriodTime frame: Day 1 (Baseline), Week 1, Months 1, 2, 3 (3-month double-blind treatment period)
- Adjusted Probability of Participants Achieving a >33% Reduction From Baseline in Number of Nocturnal Voids for All During-Treatment Visits up to Month 3Time frame: Day 1 (Baseline), Week 1, Months 1, 2, 3 (3-month double-blind treatment period)
Locations
56 sites in 2 countries. Site status is shown where the registry gives one.
Pinnacle Research Group, LLC
Anniston, Alabama
Medical Affiliated Research Center, Inc.
Huntsville, Alabama
Radiant Research, Inc.
Scottsdale, Arizona
Premiere Pharmaceutical Research
Tempe, Arizona
Family Medical Center
Foothill Rance, California
Axis Clinical Trials
Los Angeles, California
Radiant Research, Inc.
Santa Rosa, California
Genitourinary Surgical Consultants
Denver, Colorado
Radiant Research, Inc.
Denver, Colorado
Front Range Clinical Research, LLC
Wheat Ridge, Colorado
Connecticut Clinical Research Center, LLC
Middlebury, Connecticut
South Florida Medical Research
Aventura, Florida
Women's Medical Research Group, LLC
Clearwater, Florida
Avail Clinical Research, LLC
DeLand, Florida
FPA Clinical Research
Kissimmee, Florida
Sunrise Medical Research
Lauderdale Lakes, Florida
Advanced Pharma CR, LLC
Miami, Florida
DMI Research
Pinellas Park, Florida
Pinellas Urology, Inc
St. Petersburg, Florida
Midtown Medical Center
Tampa, Florida
Advanced Research Institute, Inc.
Trinity, Florida
Radiant Research, Inc.
Atlanta, Georgia
Southeastern Medical Research Institute
Columbus, Georgia
Radiant Research, Inc.
Chicago, Illinois
Accelovance
Peoria, Illinois
Accelovance
South Bend, Indiana
FutureCare Studies, Inc.
Springfield, Massachusetts
Bay State Clinical Trials, Inc.
Watertown, Massachusetts
Beyer Research
Kalmazoo, Michigan
Radiant Research, Inc.
Edina, Minnesota
Radiant Research, Inc.
St Louis, Missouri
Radiant Research
Las Vegas, Nevada
Anderson & Collins Clinical Research Inc.
Edison, New Jersey
Urology Center Research Institute
Englewood, New Jersey
AccuMed Research Associates
Garden City, New York
University Urology Associates
New York, New York
Radiant Research, Inc.
Akron, Ohio
Community Research
Cincinnati, Ohio
Complete HealthCare
Columbus, Ohio
Urologic Consultants of SE PA
Bala-Cynwyd, Pennsylvania
Showing 40 of 56 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.